Add OPORF to Watchlist?
  • Easy Tracking In The Watchlist

OPORF Performance

OPORF Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Apr 10, 2025 May 16, 2025 Jun 11, 2025 $0.0027 1.13%
2 May 15, 2025 May 15, 2025 Jun 11, 2025 $0.0026 1.09%
3 Apr 18, 2024 Apr 18, 2024 May 20, 2024 $0.0025 0.711%
4 May 04, 2023 May 04, 2023 Jun 09, 2023 $0.0045 3.00%

FAQ

What is the symbol for Open Orphan Plc Stock and on which exchange is it traded?
The symbol for Open Orphan Plc is OPORF and it is traded on the PINK (Pink Sheets).

Should I buy or sell Open Orphan Plc Stock?
Based on market data through Aug 10, 2026, StockInvest.us rates Open Orphan Plc (OPORF) as Hold/Accumulate with a technical score of 0.00 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation. Since the Hold signal began on Jun 16, 2026, the price has remained flat. The current 3-month trend forecast projects a fall of 70.51%.

How to buy Open Orphan Plc Stock?
Open Orphan Plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Open Orphan Plc Stock.

What's the current price of Open Orphan Plc Stock?
As of the end of day on the Aug 10, 2026, the price of an Open Orphan Plc (OPORF) share was $0.110.

What is the 52-week high and low for Open Orphan Plc Stock?
The 52-week high for Open Orphan Plc Stock is $0.350 and the 52-week low is $0.0861.

What is the market capitalization of Open Orphan Plc Stock?
As of the Aug 10, 2026, the market capitalization of Open Orphan Plc is 75.449M.

When is the next earnings date for Open Orphan Plc?
The upcoming earnings date for Open Orphan Plc is Sep 15, 2026.
Click to get the best stock tips daily for free!
ABOUT OPEN ORPHAN PLC
Open Orphan
Open Orphan Plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 h...
GOLDEN STAR
Ticker Change Signal Date
GPOR
$158.45
6.03% Aug 06
FCX
$62.63
12.61% Jul 31
BIIB
$202.19
2.44% Jul 24
TSCO
$30.32
14.18% Jul 23
S
SW
$43.71
8.88% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE